Retinoblastoma protein switches the E2F site from positive to negative element
- 16 July 1992
- journal article
- letter
- Published by Springer Nature in Nature
- Vol. 358 (6383) , 259-261
- https://doi.org/10.1038/358259a0
Abstract
ORIGINALLY E2F sites were identified as elements in the promoters of adenovirus early genes that are necessary for activation of these genes by the early protein E1a (ref. 1). E2F promoter elements have been shown to be important for transcriptional activation of several genes critical for progression through the cell cycle2–4. During the G1 phase of the cell cycle, the E2F protein forms a complex with the cell-cycle protein Rb (ref. 5) and it has been suggested that this binding of Rb to E2F inactivates E2F (ref. 5). Here we show that Rb-E2F is an active complex that, when bound to the E2F site, inhibits the activity of other promoter elements and thus silences transcription. We propose that the ability of this complex to inhibit transcription is integral to the function of Rb and provide evidence that E2F is a positive element in the absence of an active form of Rb. It has been shown that binding of Rb to E2F depends on the phosphorylation state of Rb (only the underphosphorylated form binds)5 and that the phosphorylation state of Rb changes during progression through the cell cycle6,7. We therefore suggest that the E2F site alternates between a positive and negative element with the phosphorylation/dephosphorylation cycle of Rb. This cyclic activity may be responsible for activating and then inhibiting genes during the cell cycle.Keywords
This publication has 19 references indexed in Scilit:
- The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding proteinCell, 1991
- The E2F transcription factor is a cellular target for the RB proteinCell, 1991
- Negative regulation of human c-fos expression by thes retinoblastoma gene productNature, 1990
- Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: A novel mechanism for E1A trans-activationCell, 1990
- The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large TCell, 1990
- The retinoblastoma protein is phosphorylated during specific phases of the cell cycleCell, 1989
- Nuclear factor E2F mediates basic transcription and trans-activation by E1a of the human MYC promoter.Genes & Development, 1989
- Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene productNature, 1988
- Role of an adenovirus E2 promoter binding factor in E1A-mediated coordinate gene control.Proceedings of the National Academy of Sciences, 1987
- The adenovirus type 5 E1A transcriptional control region contains a duplicated enhancer elementCell, 1983